The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human,
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …

Dengue is the most prevalent mosquito-borne viral disease worldwide. Yet, there are no
vaccines or specific antivirals available to prevent or treat the disease. Several dengue …

The COVID-19 pandemic urgently needs therapeutic and prophylactic interventions. Here,
we report the rapid identification of SARS-CoV-2-neutralizing antibodies by high-throughput …

Dengue is the most common viral infection spread by mosquitoes, prevalent in tropical
countries. The acute dengue virus (DENV) infection is a benign and primarily febrile illness …

Due to the lack of an effective therapeutic treatment to flavivirus, dengue virus (DENV)
nonstructural protein 1 (NS1) has been considered to develop a vaccine owing to its lack of …

Influenza virus has the ability to evade host immune surveillance through rapid viral genetic
drift and reassortment; therefore, it remains a continuous public health threat. The …

In the past two decades there has been a significant expansion in the number of new
therapeutic monoclonal antibodies (mAbs) that are approved by regulators. The discovery of …

Severe dengue is caused by host responses to viral infection, but the pathogenesis remains
unknown. This is, in part, due to the lack of suitable animal models. Here, we report a non …

Dengue virus (DENV), from the genus flavivirus of the family flaviviridae, causes serious
health problems globally. Human monoclonal antibodies (HuMAb) can be used to elucidate …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019 (COVID-19). SARS-CoV-2 has been spreading worldwide since …